[Clinical use and experimental studies of eye drops using a vasoconstror substance (Biciron)].
D000818:Animals; D001548:Benzalkonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003231:Conjunctivitis / Q000188:drug therapy; D004338:Drug Combinations; D005128:Eye Diseases / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced / Q000188:drug therapy; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007767:Lacrimal Duct Obstruction / Q000188:drug therapy; D009883:Ophthalmic Solutions; D011817:Rabbits; D012835:Silver Nitrate; D013012:Sorbitol / Q000008:administration & dosage / Q000627:therapeutic use*; D014043:Tolazoline; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001548:Benzalkonium Compounds; D004338:Drug Combinations; D007093:Imidazoles; D009883:Ophthalmic Solutions; D014662:Vasoconstrictor Agents; D013012:Sorbitol; D012835:Silver Nitrate; D014043:Tolazoline
Klinische Anwendung und experimentelle Untersuchung von Augentropfen mit einer gefässverengernden Substanz (Biciron.